| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/10/2006 | US20060178311 Control of lactation |
| 08/10/2006 | US20060178310 Intracellular delivery of biological effectors |
| 08/10/2006 | US20060178309 Method for the crystallization of human serum albumin |
| 08/10/2006 | US20060178308 Complement inhibitor |
| 08/10/2006 | US20060178307 Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor |
| 08/10/2006 | US20060178306 Treating amyotrophic lateral sclerosis (ALS) by administering a transthyretin protein, 7B2 protein, a cystatin C protein, a neuroendocrine protein, a cysteine protease inhibitor, or an inhibitor of an enzyme that processes a 7B2 protein |
| 08/10/2006 | US20060178305 Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof |
| 08/10/2006 | US20060178304 Stabilized pharmaceutical peptide compositions |
| 08/10/2006 | US20060178303 Potassium channel blockers |
| 08/10/2006 | US20060178302 Amyloid beta protein (globular assembly and uses thereof) |
| 08/10/2006 | US20060178301 Albumin-fused ciliary neurotrophic factor |
| 08/10/2006 | US20060178300 Heterocarpine, a plant-derived protein with anti-cancer properties |
| 08/10/2006 | US20060178299 Therapeutic epitopes and uses thereof |
| 08/10/2006 | US20060178298 Aplidine and aplidine analogues are of use for the treatment of cancer, in particular in the treatment of leukemias and lymphomas, especially in combination therapies |
| 08/10/2006 | US20060178296 Night-time oral insulin therapy |
| 08/10/2006 | US20060178295 androgen steroid conjugated with one or more mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit a synergistic action together with a cytoskeleton-acting drug such as Taxol (reg); prostate cancer |
| 08/10/2006 | US20060178294 comprises a N-acyl sarcosine; for identifying and/or quantifying variants and aberrant forms of hemoglobin; cell-by-cell measurement for different red blood cell subpopulations such as in both mature red blood cells and reticulocytes simultaneously |
| 08/10/2006 | US20060178293 Cardiotonic polypeptides |
| 08/10/2006 | US20060177932 Expansion agents for stem cells |
| 08/10/2006 | US20060177911 Delta 4,5 glycuronidase and methods of cleaving therewith |
| 08/10/2006 | US20060177910 Delta 4,5 glycuronidase and methods of hydrolyzing therewith |
| 08/10/2006 | US20060177908 Il-2 transmembrane construct |
| 08/10/2006 | US20060177906 IGF-I responsive gene and use thereof |
| 08/10/2006 | US20060177904 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders |
| 08/10/2006 | US20060177903 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| 08/10/2006 | US20060177902 mammalian cytokine receptor proteins with affinity for IL-13; allergic conditions, asthma, immune complex disease; lupus, nephrotic syndrome, nephritis, glomerulonephritis, thyroiditis and Grave's disease |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177898 Methods for producing modified glycoproteins |
| 08/10/2006 | US20060177885 Delta 4,5 glycuronidase and methods of analyzing therewith |
| 08/10/2006 | US20060177866 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 08/10/2006 | US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 08/10/2006 | US20060177854 Hereditary hemochromatosis gene |
| 08/10/2006 | US20060177829 Contacting human beta-transducin repeat containing protein ( beta -TrCP) beta -TrCP1 or beta -TrCP2 with test compound and a phosphorylated cell division cycle 25A (Cdc25A) protein or a phosphorylated fragment thereof; detecting reduced binding compared to control; drug screening; anticarcinogenic agents |
| 08/10/2006 | US20060177543 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/10/2006 | US20060177523 Administration of a thiol-based chemoprotectant compound |
| 08/10/2006 | US20060177514 Preparation of a therapeutic composition |
| 08/10/2006 | US20060177503 Bambuterol and integrin inhibitor combination and treatment method |
| 08/10/2006 | US20060177500 Solid dispersion of tacrolimus |
| 08/10/2006 | US20060177492 Collagen gel and process of producing the same |
| 08/10/2006 | US20060177479 Methods and devices for promoting epithelial cell differentiation and keratinization |
| 08/10/2006 | US20060177475 Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
| 08/10/2006 | US20060177470 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 08/10/2006 | US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/10/2006 | US20060177459 Treatment and diagnosis of infertitlity using TGFbeta or activin |
| 08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 08/10/2006 | US20060177456 Apo-2 receptor antibodies |
| 08/10/2006 | US20060177454 Method of promoting an immune response with a bispecific antibody |
| 08/10/2006 | US20060177444 Concomitant drug as therapeutic agent for inflammatory bowel disease |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177442 Using cytokine receptor (CD30) specific immunoglobulin to treat hodgkin's disease |
| 08/10/2006 | US20060177434 Reduction of adipose tissue |
| 08/10/2006 | US20060177433 Treatment of alpha-galactosidase a deficiency |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | US20060177431 Inhibitors for continuous activation of calcineurin |
| 08/10/2006 | US20060177430 Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer |
| 08/10/2006 | US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders |
| 08/10/2006 | US20060177427 DNA coding for endo-beta-galactosidase |
| 08/10/2006 | US20060177423 Composition and method for killing of tumours |
| 08/10/2006 | US20060177422 co-expressing bicistronically caspase 4 with the human precursor IL-18 polypeptide and purifying the active polypeptide |
| 08/10/2006 | US20060177421 Treatment of allergic conditions by use of il 21 |
| 08/10/2006 | US20060177420 treatment of a tumor by administering to a patient an effective amount of active dendritic cells (DC) that are tumor-specific and secrete IL12 |
| 08/10/2006 | US20060177419 Stimulating neutrophil function to treat inflammatory bowel disease |
| 08/10/2006 | US20060177418 Using bioactive compounds to induce or accelerate healing of damaged skin |
| 08/10/2006 | US20060177417 Packaged form containing complex of polypeptide and macromolecular carrier |
| 08/10/2006 | US20060177387 Compositions comprising bone marrow cells, demineralized bone matrix and various site-reactive polymers for use in the induction of bone and cartilage formation |
| 08/10/2006 | DE60115222T2 Kombination von defibrotid und g-csf und ihre verwendung zur aktivierung hämatopoietischer vorläuferzellen Progenitor cell combination of defibrotide and g-csf and their use for the activation of hematopoietic |
| 08/10/2006 | DE112004001553T5 Verpflanzungsmaterialien, die bioaktive Substanzen enthalten, und Methoden zu deren Herstellung Transplant materials containing bioactive substances, and methods for their preparation |
| 08/10/2006 | DE102005005542A1 Preparing interleukin-2 (IL-2) for pharmaceutical use, by adding sodium dodecyl sulfate to composition comprising IL-2, removing precipitated covalently-linked IL-2 multimers, and reducing sodium dodecyl sulfate concentration |
| 08/10/2006 | CA2597152A1 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting) |
| 08/10/2006 | CA2597146A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventif fibrotic disease |
| 08/10/2006 | CA2596966A1 Implantable osmotic device for continuous delivery of suspension formulations |
| 08/10/2006 | CA2596842A1 Synthetic peptide copolymers for treatment and prevention of cardiovascular disorders |
| 08/10/2006 | CA2596674A1 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 08/10/2006 | CA2596672A1 Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 08/10/2006 | CA2596514A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 08/10/2006 | CA2596366A1 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
| 08/10/2006 | CA2596332A1 Anti-t cell and autoantigen treatment of autoimmune disease |
| 08/10/2006 | CA2596280A1 Compositions and methods for less immunogenic protein formulations |
| 08/10/2006 | CA2596255A1 Compositions containing the anti-angiogenic phscn-peptide |
| 08/10/2006 | CA2596248A1 Method to identify polypeptide toll-like receptor (tlr) ligands |
| 08/10/2006 | CA2596079A1 Novel polypeptide ligands for toll-like receptor 2 (tlr2) |
| 08/10/2006 | CA2595786A1 Compositions and methods for treating fibrotic disorders |
| 08/10/2006 | CA2593846A1 Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders |
| 08/10/2006 | CA2593714A1 Survivin peptide vaccine |
| 08/09/2006 | EP1688498A1 A recombinant protein with cancer suppression action, its encoding gene and use |
| 08/09/2006 | EP1688496A2 Regulation of human P2Y1-like G protein-coupled receptor |
| 08/09/2006 | EP1688495A1 MU-1 member of the cytokine receptor family |
| 08/09/2006 | EP1688486A1 Antibacterial peptide and utilization of the same |
| 08/09/2006 | EP1688439A1 Fused protein composition |
| 08/09/2006 | EP1688431A2 Analogs of thymosin alpha 1 |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688427A1 Perindopril |
| 08/09/2006 | EP1688420A1 5-5-membered fused heterocyclic compound and use thereof as hcv polymerase inhibitor |
| 08/09/2006 | EP1688156A2 A filtrate composition for use in dialysis via the colon |
| 08/09/2006 | EP1688148A1 Combination treatment using exendin-4 and thiazolidinediones |
| 08/09/2006 | EP1688147A1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon |
| 08/09/2006 | EP1688146A1 Preparing aldesleukin for pharmaceutical use |
| 08/09/2006 | EP1688134A2 Dry powder inhaler for transpulmonary administration |
| 08/09/2006 | EP1688133A1 Freeze-dried composition for transpulmonary administration |
| 08/09/2006 | EP1687630A2 Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepl1) |